Ensign Peak Advisors, Inc Beam Therapeutics Inc. Transaction History

Ensign Peak Advisors, Inc

  • $56.1 Billion
  • Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 29,111 shares of BEAM stock, worth $736,217. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,111
Previous 29,111 -0.0%
Holding current value
$736,217
Previous $682,000 4.55%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$23.46 - $45.07 $34,462 - $66,207
-1,469 Reduced 4.8%
29,111 $961,000
Q2 2023

Aug 14, 2023
BUY
$29.32 - $35.99 $65,970 - $80,977
2,250 Added 7.94%
30,580 $976,000
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $84,420 - $136,612
2,800 Added 10.97%
28,330 $867,000
Q4 2022

Feb 13, 2023
BUY
$36.73 - $51.6 $433,413 - $608,880
11,800 Added 85.94%
25,530 $998,000
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $2.42 Million - $4.27 Million
-60,757 Reduced 81.57%
13,730 $654,000
Q2 2022

Aug 12, 2022
BUY
$29.86 - $62.36 $1.97 Million - $4.12 Million
66,047 Added 782.55%
74,487 $2.88 Million
Q4 2021

Feb 11, 2022
SELL
$68.02 - $99.06 $1.26 Million - $1.84 Million
-18,594 Reduced 68.78%
8,440 $673,000
Q1 2021

May 12, 2021
SELL
$71.28 - $120.75 $6.65 Million - $11.3 Million
-93,273 Reduced 77.53%
27,034 $2.16 Million
Q4 2020

Feb 12, 2021
BUY
$22.24 - $95.63 $1.21 Million - $5.21 Million
54,489 Added 82.79%
120,307 $9.82 Million
Q3 2020

Nov 12, 2020
BUY
$19.0 - $30.57 $709,954 - $1.14 Million
37,366 Added 131.33%
65,818 $1.62 Million
Q2 2020

Aug 12, 2020
SELL
$15.26 - $28.66 $93,910 - $176,373
-6,154 Reduced 17.78%
28,452 $797,000
Q1 2020

May 11, 2020
BUY
$13.31 - $29.2 $460,605 - $1.01 Million
34,606 New
34,606 $623,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email